IL233893D0 - Purification of streptococcus pneumoniae type 3 polysaccharides - Google Patents

Purification of streptococcus pneumoniae type 3 polysaccharides

Info

Publication number
IL233893D0
IL233893D0 IL233893A IL23389314A IL233893D0 IL 233893 D0 IL233893 D0 IL 233893D0 IL 233893 A IL233893 A IL 233893A IL 23389314 A IL23389314 A IL 23389314A IL 233893 D0 IL233893 D0 IL 233893D0
Authority
IL
Israel
Prior art keywords
polysaccharides
purification
streptococcus pneumoniae
pneumoniae type
type
Prior art date
Application number
IL233893A
Other languages
Hebrew (he)
Other versions
IL233893A (en
Original Assignee
Wyeth Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US85066506P priority Critical
Priority to PCT/US2007/080768 priority patent/WO2008045852A2/en
Application filed by Wyeth Llc filed Critical Wyeth Llc
Publication of IL233893D0 publication Critical patent/IL233893D0/en
Publication of IL233893A publication Critical patent/IL233893A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/04Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00Drug, bio-affecting and body treating compositions
    • Y10S424/831Drug, bio-affecting and body treating compositions involving capsular polysaccharide of bacterium, e.g. polyribosyl ribitol phosphate
IL233893A 2006-10-10 2014-07-31 Methods for the separation of streptococcus pneumoniae type 3 polysaccharides IL233893A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US85066506P true 2006-10-10 2006-10-10
PCT/US2007/080768 WO2008045852A2 (en) 2006-10-10 2007-10-09 Purification of streptococcus pneumoniae type 3 polysaccharides

Publications (2)

Publication Number Publication Date
IL233893D0 true IL233893D0 (en) 2014-09-30
IL233893A IL233893A (en) 2017-04-30

Family

ID=39156240

Family Applications (2)

Application Number Title Priority Date Filing Date
IL197782A IL197782A (en) 2006-10-10 2009-03-24 Purification of streptococcus pneumoniae type 3 polysaccharides
IL233893A IL233893A (en) 2006-10-10 2014-07-31 Methods for the separation of streptococcus pneumoniae type 3 polysaccharides

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IL197782A IL197782A (en) 2006-10-10 2009-03-24 Purification of streptococcus pneumoniae type 3 polysaccharides

Country Status (19)

Country Link
US (1) US7659090B2 (en)
JP (1) JP5260531B2 (en)
KR (1) KR101467002B1 (en)
CN (2) CN102648979B (en)
AT (1) AT473289T (en)
AU (1) AU2007307800C1 (en)
BR (1) BRPI0717834A2 (en)
CA (1) CA2665169C (en)
CL (1) CL2007002909A1 (en)
DE (1) DE602007007642D1 (en)
DK (1) DK2074221T3 (en)
ES (1) ES2346929T3 (en)
HK (1) HK1174836A1 (en)
IL (2) IL197782A (en)
MX (1) MX2009003730A (en)
PT (1) PT2074221E (en)
RU (1) RU2460539C2 (en)
WO (1) WO2008045852A2 (en)
ZA (1) ZA200902502B (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0822634D0 (en) 2008-12-11 2009-01-21 Novartis Ag Meningitis vaccines
WO2010080486A2 (en) * 2008-12-18 2010-07-15 Wyeth Llc Method for controlling streptococcus pneumoniae serotype 19a polysaccharide molecular weight
MX346071B (en) 2008-12-18 2017-03-02 Wyeth Llc Method for controlling streptococcus pneumoniae polysaccharide molecular weight using carbon.
US20120064103A1 (en) 2009-03-24 2012-03-15 Novartis Ag Combinations of meningococcal factor h binding protein and pneumococcal saccharide conjugates
EP2411048A1 (en) 2009-03-24 2012-02-01 Novartis AG Adjuvanting meningococcal factor h binding protein
MX340830B (en) 2009-04-30 2016-07-26 Coley Pharm Group Inc Pneumococcal vaccine and uses thereof.
EP2585106A1 (en) 2010-06-25 2013-05-01 Novartis AG Combinations of meningococcal factor h binding proteins
CN102094053B (en) * 2010-11-26 2013-01-16 兰州生物制品研究所有限责任公司 Method for purifying streptococcus penumoniae C polysaccharide
JP6191082B2 (en) 2011-03-02 2017-09-06 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム Combination vaccine with lower dose of antigen and / or adjuvant
BR112014016223A8 (en) 2011-12-29 2017-07-04 Novartis Ag adjuvant combinations of meningococcal h-factor binding proteins
JP2015510872A (en) 2012-03-07 2015-04-13 ノバルティス アーゲー Enhanced formulation of Streptococcus pneumoniae antigen
WO2013132043A1 (en) 2012-03-08 2013-09-12 Novartis Ag Combination vaccines with tlr4 agonists
RU2015106930A (en) 2012-09-06 2016-10-20 Новартис Аг Combined vaccines with the meningococc serograph b and k / d / s
RU2606022C2 (en) 2012-09-07 2017-01-10 Ск Кемикалс Ко., Лтд. Method of producing capsular polysaccharide with pneumococcal serotype
WO2014095771A1 (en) 2012-12-18 2014-06-26 Novartis Ag Conjugates for protecting against diphtheria and/or tetanus
RU2019112411A (en) 2014-01-21 2019-05-31 Пфайзер Инк. Immunogenic compositions containing conjugated capsular saccharide antigens and their application
KR20190133066A (en) 2014-01-21 2019-11-29 화이자 인코포레이티드 Streptococcus pneumoniae capsular polysaccharides and conjugates thereof
AU2015208820A1 (en) 2014-01-21 2016-07-14 Pfizer Inc. Streptococcus pneumoniae capsular polysaccharides and conjugates thereof
KR20170102009A (en) 2015-01-15 2017-09-06 화이자 인코포레이티드 Immunogenic compositions for use in pneumococcal vaccines
AU2016254693A1 (en) 2015-04-28 2017-11-09 Biological E Limited Method for separation of protein and other impurities from microbial capsular polysaccharides
KR102045663B1 (en) 2015-05-04 2019-11-15 화이자 인코포레이티드 Group B Streptococcus polysaccharide-protein conjugate, method of producing the conjugate, immunogenic composition comprising the conjugate, and use thereof
BR112018000087A2 (en) 2015-07-21 2018-09-04 Pfizer immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising them and uses thereof
US20190000952A1 (en) 2015-11-20 2019-01-03 Pfizer Inc. Immunogenic compositions for use in pneumococcal vaccines
US20180125958A1 (en) 2016-11-09 2018-05-10 Pfizer Inc. Immunogenic Compositions and Uses Thereof
CA3048981A1 (en) 2016-12-30 2018-07-05 Sutrovax, Inc. Polypeptide-antigen conjugates with non-natural amino acids
KR20190097176A (en) 2017-01-20 2019-08-20 화이자 인코포레이티드 Immunogenic Compositions for Use in Pneumococcal Vaccines
US10435433B2 (en) 2017-07-05 2019-10-08 Inventprise, Llc Polysaccharide purification for vaccine production using lytic enzymes, tangential flow filtration, and multimode chromatography
WO2020010016A1 (en) 2018-07-04 2020-01-09 Sutrovax, Inc. Self-adjuvanted immunogenic conjugates
WO2020009993A1 (en) 2018-07-04 2020-01-09 Sutrovax, Inc. Improvements in immunogenic conjugates

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4413057A (en) * 1980-04-14 1983-11-01 Merck & Co., Inc. Group B streptococcal capsular polysaccharides
CA2059692C (en) * 1991-01-28 2004-11-16 Peter J. Kniskern Pneumoccoccal polysaccharide conjugate vaccine
CZ20013378A3 (en) * 1999-03-19 2002-03-13 Smithkline Beecham Biologicals S. A. Vaccine
JP4856345B2 (en) * 2000-03-16 2012-01-18 ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィアThe Children’S Hospital Of Philadelphia Controlled production of Pneumococcus capsular polysaccharide
GB0115176D0 (en) * 2001-06-20 2001-08-15 Chiron Spa Capular polysaccharide solubilisation and combination vaccines
US20050220777A1 (en) * 2003-11-21 2005-10-06 Stefan Roos Selection of lactic acid bacteria enhancing the immune response against Streptococcus pneumoniae
JP5049264B2 (en) * 2005-04-08 2012-10-17 ワイス・エルエルシー Separation of contaminants from Streptococcus pneumoniae polysaccharide by pH manipulation
WO2007084856A2 (en) * 2006-01-13 2007-07-26 Baxter International Inc. Method for purifying polysaccharides

Also Published As

Publication number Publication date
ES2346929T3 (en) 2010-10-21
PT2074221E (en) 2010-09-06
BRPI0717834A2 (en) 2014-06-10
AT473289T (en) 2010-07-15
IL197782D0 (en) 2011-08-01
US20080102498A1 (en) 2008-05-01
AU2007307800C1 (en) 2014-03-13
AU2007307800B2 (en) 2012-12-20
US7659090B2 (en) 2010-02-09
AU2007307800A1 (en) 2008-04-17
JP5260531B2 (en) 2013-08-14
HK1174836A1 (en) 2014-11-28
ZA200902502B (en) 2010-03-31
CN101522906A (en) 2009-09-02
WO2008045852A3 (en) 2008-06-19
KR101467002B1 (en) 2014-12-01
MX2009003730A (en) 2009-04-22
KR20090071629A (en) 2009-07-01
CL2007002909A1 (en) 2008-04-18
CN101522906B (en) 2012-05-30
RU2460539C2 (en) 2012-09-10
JP2010505963A (en) 2010-02-25
DK2074221T3 (en) 2010-09-06
IL197782A (en) 2014-08-31
DE602007007642D1 (en) 2010-08-19
CN102648979A (en) 2012-08-29
IL233893A (en) 2017-04-30
CA2665169C (en) 2017-02-21
CN102648979B (en) 2014-05-14
CA2665169A1 (en) 2008-04-17
WO2008045852A2 (en) 2008-04-17
RU2009112453A (en) 2010-11-20

Similar Documents

Publication Publication Date Title
IL211664D0 (en) Streptococcus pnevmoniae immunogenic
EP2089034A4 (en) Novel uses
ZA200810613B (en) Toothbrush
GB0624290D0 (en) Novel compositions
WO2009014731A9 (en) Architectural physical synthesis
IL198231D0 (en) Pyridine carboxamides as 11??hsd1 inhibitors
EP1971252A4 (en) Over-tube
ZA200807763B (en) Oligosaccharide mixture
EP2049296A4 (en) Chatter-resistant end mill
AT473289T (en) Improved methods of separating streptococcus pneumoniae-3 polysaccharides
EP2098517A4 (en) Novel phenyl-isoxazol-3-ol derivative
HK1133037A1 (en) Macrolide derivative
ZA200809621B (en) Production of isoprenoids
IL192905D0 (en) Novel products
IL193746A (en) Antimicrobial compositions and catheters containing the same and methods for production thereof
IL198343D0 (en) Novel products
ZA200900240B (en) Antibacterial compositions
IL194489D0 (en) Bifunctionalized polysaccharides
EP1990335A4 (en) 17 beta hsd type 5 inhibitor
ZA200806847B (en) Novel products
GB0601498D0 (en) Product
EP2436700B8 (en) Shortened purification process for the production of capsular streptococcus pneumoniae polysaccharides
GB2451017B (en) Construction product
HK1132510A1 (en) Macrolide synthesis process
EP2012756A4 (en) Multiple unit compositions

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed